264 related articles for article (PubMed ID: 17259075)
21. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction.
Filep JG; Khreiss T; József L
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):257-62. PubMed ID: 15979865
[TBL] [Abstract][Full Text] [Related]
22. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin E(2) and 6-keto-prostaglandin F(1alpha) production is elevated following traumatic injury to sciatic nerve.
Muja N; DeVries GH
Glia; 2004 Apr; 46(2):116-29. PubMed ID: 15042580
[TBL] [Abstract][Full Text] [Related]
24. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
Takano T; Fiore S; Maddox JF; Brady HR; Petasis NA; Serhan CN
J Exp Med; 1997 May; 185(9):1693-704. PubMed ID: 9151906
[TBL] [Abstract][Full Text] [Related]
25. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation.
Clària J; Lee MH; Serhan CN
Mol Med; 1996 Sep; 2(5):583-96. PubMed ID: 8898374
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage.
Fiorucci S; de Lima OM; Mencarelli A; Palazzetti B; Distrutti E; McKnight W; Dicay M; Ma L; Romano M; Morelli A; Wallace JL
Gastroenterology; 2002 Nov; 123(5):1598-606. PubMed ID: 12404234
[TBL] [Abstract][Full Text] [Related]
27. Preeclampsia is associated with a deficiency of lipoxin A4, an endogenous anti-inflammatory mediator.
Xu Z; Zhao F; Lin F; Xiang H; Wang N; Ye D; Huang Y
Fertil Steril; 2014 Jul; 102(1):282-290.e4. PubMed ID: 24796762
[TBL] [Abstract][Full Text] [Related]
28. Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.
Hashimoto A; Hayashi I; Murakami Y; Sato Y; Kitasato H; Matsushita R; Iizuka N; Urabe K; Itoman M; Hirohata S; Endo H
J Rheumatol; 2007 Nov; 34(11):2144-53. PubMed ID: 17918787
[TBL] [Abstract][Full Text] [Related]
29. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.
Romano M; Maddox JF; Serhan CN
J Immunol; 1996 Sep; 157(5):2149-54. PubMed ID: 8757340
[TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent.
Machado FS; Johndrow JE; Esper L; Dias A; Bafica A; Serhan CN; Aliberti J
Nat Med; 2006 Mar; 12(3):330-4. PubMed ID: 16415877
[TBL] [Abstract][Full Text] [Related]
31. Microparticles mediate enzyme transfer from platelets to mast cells: a new pathway for lipoxin A4 biosynthesis.
Tang K; Liu J; Yang Z; Zhang B; Zhang H; Huang C; Ma J; Shen GX; Ye D; Huang B
Biochem Biophys Res Commun; 2010 Sep; 400(3):432-6. PubMed ID: 20801099
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
Takano T; Clish CB; Gronert K; Petasis N; Serhan CN
J Clin Invest; 1998 Feb; 101(4):819-26. PubMed ID: 9466977
[TBL] [Abstract][Full Text] [Related]
33. Statins enhance rotator cuff healing by stimulating the COX2/PGE2/EP4 pathway: an in vivo and in vitro study.
Dolkart O; Liron T; Chechik O; Somjen D; Brosh T; Maman E; Gabet Y
Am J Sports Med; 2014 Dec; 42(12):2869-76. PubMed ID: 25184246
[TBL] [Abstract][Full Text] [Related]
34. Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin.
Fiorucci S; Distrutti E; de Lima OM; Romano M; Mencarelli A; Barbanti M; Palazzini E; Morelli A; Wallace JL
FASEB J; 2003 Jun; 17(9):1171-3. PubMed ID: 12709408
[TBL] [Abstract][Full Text] [Related]
35. Interactions between lipoxin A4, the stable analogue 16-phenoxy-lipoxin A4 and leukotriene B4 in cytokine generation by human monocytes.
Andersson P; Serhan CN; Petasis NA; Palmblad J
Scand J Immunol; 2004 Sep; 60(3):249-56. PubMed ID: 15320881
[TBL] [Abstract][Full Text] [Related]
36. Lipoxin a4 increases survival by decreasing systemic inflammation and bacterial load in sepsis.
Walker J; Dichter E; Lacorte G; Kerner D; Spur B; Rodriguez A; Yin K
Shock; 2011 Oct; 36(4):410-6. PubMed ID: 21701419
[TBL] [Abstract][Full Text] [Related]
37. Anti-inflammatory effects of lipoxins on lipopolysaccharide-induced uveitis in rats.
Karim MJ; Bhattacherjee P; Biswas S; Paterson CA
J Ocul Pharmacol Ther; 2009 Dec; 25(6):483-6. PubMed ID: 20021273
[TBL] [Abstract][Full Text] [Related]
38. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
Parkinson JF
Inflamm Allergy Drug Targets; 2006 Apr; 5(2):91-106. PubMed ID: 16613568
[TBL] [Abstract][Full Text] [Related]
39. Myocardial 15-epi-lipoxin A4 generation provides a new mechanism for the immunomodulatory effects of statins and thiazolidinediones.
Levy BD
Circulation; 2006 Aug; 114(9):873-5. PubMed ID: 16940203
[No Abstract] [Full Text] [Related]
40. Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
Vainio M; Riutta A; Koivisto AM; Mäenpää J
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1119-23. PubMed ID: 15548142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
